Sequenom Files Premarket 510(k) Notification with FDA for IMPACT Dx System
October 02, 2013 at 19:43 PM EDT
Sequenom (NASDAQ: SQNM ) today announced that it has submitted Premarket 510(k) Notifications to the United States Food and Drug Administration (FDA) for its IMPACT Dx™ System and its IMPACT Dx™ Factor V Leiden and Factor II Genotyping Test. The system and test are intended for use in the
